Search research articles
Contact Us
Filters
Showing results (181-190 of 228) with videos related to
Page
of 23
Sort By:
Bone
|
February 14, 2003
Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm nonpagetic cortical bone
D H Gutteridge, R W Retallack, L C Ward, et al.
Clinical Endocrinology
|
December 14, 2005
Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
T W K Ng, G F Watts, B G A Stuckey, et al.
Molecular Cancer Therapeutics
|
September 11, 2013
A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo
Fardokht Abulwerdi, Chenzhong Liao, Meilan Liu, et al.
Journal of Medicinal Chemistry
|
January 2, 2025
Discovery of High-Affinity SMARCA2/4 Bromodomain Ligands and Development of Potent and Exceptionally Selective SMARCA2 PROTAC Degraders
Lingying Leng, Wenbin Tu, Lin Yang, et al.
Journal of Medicinal Chemistry
|
May 3, 2017
Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor
Yujun Zhao, Longchuan Bai, Liu Liu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 25, 2023
Long-term Outcomes of Testosterone Treatment in Men: A T4DM Postrandomization Observational Follow-up Study
David J Handelsman, Mathis Grossmann, Bu B Yeap, et al.
Research Square
|
June 17, 2024
Comprehensive Analyses of the Effects of the Small-Molecule Inhibitor of the UHM Domain in the Splicing Factor <i>U2AF1</i> in Leukemia Cells
Xinrui Yuan, Mona Kazemi Sabzvar, Amol D Patil, et al.
Journal of Medicinal Chemistry
|
September 23, 2024
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader
Atsunori Kaneshige, Yiqing Yang, Longchuan Bai, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 30, 2025
Response to Letter to the Editor From Lin et al: "Testosterone Treatment, Weight Loss, and Health-Related Quality of Life and Psychosocial Function in Men: A 2-Year Randomized Controlled Trial"
Mathis Grossmann, Kristy P Robledo, Mark Daniel, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 11, 2021
Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCT
Mark Ng Tang Fui, Rudolf Hoermann, Karen Bracken, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 228) with videos related to
Sort By:
Page
of 23
Bone
|
February 14, 2003
Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm nonpagetic cortical bone
D H Gutteridge, R W Retallack, L C Ward, et al.
Clinical Endocrinology
|
December 14, 2005
Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
T W K Ng, G F Watts, B G A Stuckey, et al.
Molecular Cancer Therapeutics
|
September 11, 2013
A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivo
Fardokht Abulwerdi, Chenzhong Liao, Meilan Liu, et al.
Journal of Medicinal Chemistry
|
January 2, 2025
Discovery of High-Affinity SMARCA2/4 Bromodomain Ligands and Development of Potent and Exceptionally Selective SMARCA2 PROTAC Degraders
Lingying Leng, Wenbin Tu, Lin Yang, et al.
Journal of Medicinal Chemistry
|
May 3, 2017
Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor
Yujun Zhao, Longchuan Bai, Liu Liu, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 25, 2023
Long-term Outcomes of Testosterone Treatment in Men: A T4DM Postrandomization Observational Follow-up Study
David J Handelsman, Mathis Grossmann, Bu B Yeap, et al.
Research Square
|
June 17, 2024
Comprehensive Analyses of the Effects of the Small-Molecule Inhibitor of the UHM Domain in the Splicing Factor <i>U2AF1</i> in Leukemia Cells
Xinrui Yuan, Mona Kazemi Sabzvar, Amol D Patil, et al.
Journal of Medicinal Chemistry
|
September 23, 2024
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader
Atsunori Kaneshige, Yiqing Yang, Longchuan Bai, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 30, 2025
Response to Letter to the Editor From Lin et al: "Testosterone Treatment, Weight Loss, and Health-Related Quality of Life and Psychosocial Function in Men: A 2-Year Randomized Controlled Trial"
Mathis Grossmann, Kristy P Robledo, Mark Daniel, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 11, 2021
Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCT
Mark Ng Tang Fui, Rudolf Hoermann, Karen Bracken, et al.
Page
of 23